Emerging and reemerging bacterial infectious diseases are a major public health concern worldwide. The role of bacteriophages in the emergence of novel bacterial pathogens by horizontal gene transfer was highlighted by the May 2011 Escherichia coli O104:H4 outbreaks that originated in Germany and spread to other European countries. This outbreak also highlighted the pivotal role played by recent advances in functional genomics in rapidly deciphering the virulence mechanism elicited by this novel pathogen and developing rapid diagnostics and therapeutics. However, despite a steady increase in the number of phage sequences in the public databases, boosted by the next-generation sequencing technologies, few functional genomics studies of bacteriophages have been conducted. Our definition of 'functional genomics' encompasses a range of aspects: phage genome sequencing, annotation and ascribing functions to phage genes, prophage identification in bacterial sequences, elucidating the events in various stages of phage life cycle using genomic, transcriptomic and proteomic approaches, defining the mechanisms of host takeover including specific bacterial^phage protein interactions and identifying virulence and other adaptive features encoded by phages and finally, using prophage genomic information for bacterial detection/diagnostics. Given the breadth and depth of this definition and the fact that some of these aspects (especially phage-encoded virulence/adaptive features) have been treated extensively in other reviews, we restrict our focus only on certain aspects. These include phage genome sequencing and annotation, identification of prophages in bacterial sequences and genetic characterization of phages, functional genomics of the infection process and finally, bacterial identification using genomic information.
INTRODUCTION
Infectious diseases are a constant threat to human health and the second most frequent cause of death, with an estimated more than 10 million fatalities worldwide annually. Amongst the top five foodborne diseases worldwide, four are caused by bacterial pathogens, such as Salmonella, Clostridium, Campylobacter and Staphylococcus, and are responsible for more than 3 million infections and intoxications in the USA alone in 2011 [1] . In the European Union, foodborne infections by Salmonella, Campylobacter and Listeria account for more than 300 000 human cases of infection annually [2] . By their nature, bacteriophages (phages), viruses that infect bacteria, are ideal weapons to combat bacterial infections. They are highly species-specific, and are non-toxic to animals and plants and they are self-amplified when they infect, multiply and kill their target bacteria [3] . Bacteriophages are the most abundant biological entity on this planet and it is estimated that phages kill half of all bacteria each day and influence most of earth's biogeochemistry through their bacterial host [4, 5] . Since their discovery in 1915 and 1917 by D'Herelle and Twort [6, 7] , bacteriophages have been used primarily as research tools in the Western world and as antibacterial agents in the former Soviet Union countries and Eastern Europe. The discovery of antibiotics led to the complete abandonment of phage therapy by the West [8, 9] and, hence, phages are not as widely used as therapeutics as one would imagine. The widespread use, and in many instances misuse, of antibiotics since the 1940s, in a variety of healthcare settings to combat bacterial infections in humans and livestock, has resulted in the current crisis with antibiotic resistant bacteria. Recently, phage therapy and biocontrol approaches have received renewed research interest. It is believed that the antibiotic potential of phages has not yet been fully realized [3, 8, [10] [11] [12] .
The modern day phage therapy attempts of the Western world started around 1980. In a pioneering study, Smith and Huggins successfully eradicated experimentally-induced Escherichia coli infection in a mouse infection model [13] . Since then, similar studies have been conducted to cure infections of many bacteria such as Staphylococcus aureus, VancomycinResistant Enterococci (VRE), Methicillin-Resistant Staphylococcus aureus (MRSA) in animals, Acinetobacter baumanii or Pseudomonas aeruginosa and animals with local and systemic disease caused by Vibrio vulnificus, Mycobacterium avium, Mycobacterium tuberculosis in macrophages, E. coli and fish pathogens. Phages have also been used in treating non-systemic infections caused by enteropathogenic strains of E. coli in calves, pigs and lambs and ileocecitis caused by Clostridium difficile in hamsters. Phages have been shown to be effective in preventing the destruction of skin grafts by P. aeruginosa, against fish pathogens in aquaculture and bacterial wilt in vegetables [14] [15] [16] [17] . Bacteriophages have more recently been used in various other applications to counter pathogenic bacteria. The use of bacteriophage preparations or bacteriophage-derived enzymes for detection and control of pathogens in the food chain has recently attracted intensive research (e.g. reviewed in [18, 19] ). Some additional examples include the detection of Listeria, Bacillus orYersinia by reporter phages carrying luciferase genes, which are expressed upon infection and transcription of phage genes [20] [21] [22] [23] and the biocontrol of pathogenic bacteria in food [24] [25] [26] [27] (reviewed in [28] ).
Bacteriophages, especially those featuring a temperate lifestyle, are also the major driving force of horizontal gene exchange and bacterial evolution [29] [30] [31] . Many bacterial genomes carry either complete and fully functional prophages or defective remnants of prophages indicative of prior infections. In many cases, they account for a significant proportion of the bacterial genomic content. For example, Streptococcus pyogenes features a genome with more than 10% phage-related sequences [32] , and in E. coli O157:H7 strain Sakai, prophage elements account for 16% of the total genome [33] . In many instances, the prophages confer adaptive features to their host; these include genes related to bacterial virulence, antibiotic resistance cassettes or toxin genes in a variety of organisms [29, 32] . For example, CTX phage of Vibrio cholerae [34, 35] or shiga-toxin carrying lambdoid prophages of pathogenic E. coli, such as the serotype O104:H4, responsible for the recent outbreak in Germany [36] .
In the classical sense, bacteriophage functional genomics includes DNA sequencing of phage genomes, annotation and attribution of functions based on in silico approaches and or biochemical or genetic studies and identifying prophage regions in bacterial sequences. With the recent expansion of 'omics' areas, it can also include the elucidation of various stages of phage infection process using genomic, transcriptomic and proteomic approaches, specific mechanisms that phages adopt to shut down and take over host macromolecular machinery for their own reproduction and growth, and the study of the interaction between specific bacterial and phage proteins. For this review, we focus on three specific areas: (i) recent advances in bacterial and phage genomics, tools for identifying prophage regions and genetic characterization of phages; (ii) functional genomics of the infection process and (iii) using phage genomic data for bacterial identification in clinical and non-clinical samples.
Bacteriophage genome sequencing
Obtaining the complete genome sequence of a bacteriophage is an essential prerequisite for any type of functional genomics study as well as for regulatory approval for phage-based biocontrol and therapy applications in food industry and medicine. Recent advances in second-and third-generation DNA sequencing technologies have led to an increasing number of phage genomic sequences, either from purified virus particles or as a result of bacterial genome sequencing in the form of prophage sequences [37] . Conventional Sanger sequencing has been rivaled by a number of second-generation high throughput short-read sequencing technologies (e.g. 454, Illumina, SOLiD and Ion Torrent) and lately by a third-generation single-molecule longread sequencing technology (e.g. PacBio RS by Pacific Biosciences), all of which produce more than enough data to reliably assemble phage genomes. Although the short-read sequencing technologies produce large amounts of short, accurate reads, they also produce context-specific errors, which make error correction by the same method difficult. In addition, because of the short read length, repetitive genome sequences are difficult to assemble. Recent improvements in chemistry and device design are targeted to address these problems. For example, single read lengths of up to 1000 bp can be achieved using the latest FLX plus chemistry of the Roche 454 sequencing platform. Other approaches include the generation of paired-end long insert libraries, which provide scaffolding information [37] . However, single-molecule sequencing using third-generation PacBio RS technology produces by far the longest read lengths, although the individual reads are error prone and feature single-pass accuracies of only around 87%. Since the primary error model consists of truly random single nucleotide indels, these reads can be corrected by an increase in sequencing coverage either by circular consensus sequencing or with data from other sequencing platforms, e.g. Illumina data for error correction [37] [38] [39] . Error correction by deep sequencing is an especially attractive option, as it requires only one long-insert library and a single sequencing run. Thus, reliable bacteriophage whole genome sequencing, regardless of the technology used, is possible and competitively priced. Nextgeneration sequencing technologies have also brought about the democratization of whole genome sequencing because of the smaller foot print needed in terms of cost, space and manpower. Hence, generating sequence data is within any researcher's reach. However, data handling, storage and analysis are not trivial [37] .
In addition to more than 1700 bacteriophage genomes, the above described advances in DNA sequencing technologies have enabled the generation of more than 3500 complete and 11 000 incomplete bacterial genome sequences (Gold genomes database, November 2012). In many genome-sequencing projects, the presence of integrated genomes of temperate phages (prophage) in the host chromosome is overlooked or not assessed. Conservative estimates show the presence of prophages in nearly 50% of all sequenced bacterial strains, with prophages contributing up to 20% of a bacterial genome [40] . Thus, the phage gene pool is larger and more diverse than the rest of the chromosome.
Bacteriophage genome annotation
More than 50% of in silico predicted phage gene products are hypothetical and do not have an assigned function due to a lack of experimental data. For instance, phage T4 (one of the most extensively characterized bacteriophages) genome has about 300 probable genes (168 903 bp genome size) and almost half of these still do not have an assigned function [41] . Several approaches have been put forth to solve the problem of assigning functions to hypothetical gene products (encoded by predicted open reading frames with no homology to any known gene) in all phage genomes. Recently developed bioinformatic tools, such as the structure/function prediction tool HHPred [42] make use of Hidden Markov Models (HMMs) and protein profiles to deduce putative protein functions and identify functional domains in larger proteins. Comparative genomic approaches using closely related phages from different host organisms can fill another gap in protein function assignment. Some information can be deduced from the genetic context or location of genes of interest, because phage genomes are organized in a modular fashion [31, 43] and mosaicism (i.e. the exchange of genetic modules between phages) is very common. The recent surge of interest in phage-based antimicrobials has led to more studies being published describing the experimental characterization of specific phage proteins, e.g. tail adhesins [44] [45] [46] [47] , host takeover genes [48, 49] , core genes with therapeutic potential [50] or lysins (see below).
Many of the hypothetical phage proteins are likely involved in host recognition and, disruption of host metabolism; hence, are potential candidates for bacterial detection and antimicrobial target selection, respectively. This reasoning is best illustrated by a pioneering study on drug discovery through phage genomics, in which investigators at PhageTech Inc. used 27 S. aureus phage genome sequences to screen potential drug targets. Screening a total of 964 ORFs for abolition of bacterial growth produced 34 distinct families of growth-inhibitory proteins (3.5%) [10, 51] . This screen excluded the obvious growth inhibitory proteins such as holins, lysins or polypeptides with transmembrane domains. With an increase in the number of genes with assigned functions, future comparative genomic studies will likely yield more accurate prediction of phage gene functions. Thus, functional genomics approaches, either in silico or experimental, present a vast potential for improving phage annotation and facilitating development of tools for food safety and medicine.
Prophage identification and using prophages as markers for bacterial identification
Assuming an average of three prophage regions per genome [52] , there is a potential for as many as 42 000 prophage genomes available for data mining in the currently available bacterial genome sequences-22 times the number of currently sequenced bacteriophage genomes. Even without prophage identification, genes encoding enzymes of interest, such as phage lysins (see below) can easily be identified using HMMs or BLAST searches. If, however, the objective of a study is to generate phage tail-based molecular diagnostic tools or tail-based bacteriocins (see below), prophage identification is needed. The same holds true if the study objective is to generate a synthetic phage genome for detection or eradication of specific bacterial taxa, as homology of tail proteins can be too low for HMM or BLAST detection and the nucleotide sequence of the entire prophage is needed to construct synthetic variants.
A number of bioinformatic tools have been developed for prophage identification in bacterial sequences, including Phage_Finder, one of the first automated prophage-finding open source programs developed. Since the publication of Phage_Finder [52] , there have been at least five other prophagefinding tools described in the literature [53] [54] [55] [56] . Phage_Finder is written in PERL and uses BLASTP matches to a curated phage database and HMM matches to phage-specific models to define the rough location of a prophage region followed by heuristic decision making to extend the region based on annotation. Putative attachment (att) sites are found using one of many different local alignment options. Prophinder [54] , also written in PERL also uses BLASTP matches to a database, but chooses regions based on probability statistics rather than heuristics. PHAST [55] is a web server that also uses homology to identify prophage regions, but is unique in that it does not require an annotated genome as input. Prophages have also been identified based on nucleotide differences [53] , training of artificial neural networks [57] or using a combination of AT/GC skew, protein length, gene directionality, homology and k-mer frequencies using a random forest classification algorithm [56] . Though each publication claims their software to be better than the previously reported programs at finding a set of 'known' prophage regions, the value of these comparisons is unclear, since each group has a different definition of what constitutes a true prophage. As modified from a previous review on bacteriophage bioinformatics [58] , a prophage region is defined as 'a cluster or stretch of genes, possibly encoding proteins with bacteriophage-like core functions (i.e. terminase, portal, capsid), interspersed with genes of unknown function or functions other than phage replication, morphogenesis, packaging, immunity or lysis of the host'. Ultimately, a true prophage is inducible, whereas defective prophages are the non-inducible remnants of formerly functional temperate bacteriophages. In addition, some comparisons may have been skewed since Phage_Finder can run under two different stringency modes, producing radically different results. PhiSpy [56] uses a training set based on known prophages in closely related organisms to train the random forest classification algorithm implemented in the R statistical package, which by definition should produce better results than other programs because the training set is highly related to the prophages being identified.
Phage-Finder does more than just finding prophage regions-it takes advantage of the power of HMMs to identify, with high confidence, specific phage genes of interest. Lysins, toxins and tail components can be mined for applications in bacterial detection or destruction (see below). In addition, HMM matches to family-specific proteins can be used to characterize the prophage region (e.g. Mu-like or P2-like prophage).
These in silico approaches to prophage identification are also successful at identifying cryptic, defective prophages or remnants of prophages. One such class of defective prophages is the phage tail-like bacteriocins (PTLBs), for which the P. aeruginosa R-type or F-type pyocins are the prototypes [59] . PTLB regions are defective prophages which are different from prophage regions in that they primarily contain genes for tail fibers and tail appendages, regulators and lysis genes, but lack genes for packaging and head morphogenesis. PTLB particles can kill bacteria of similar species by disrupting the membrane of the target bacteria [60] . [61] . Like bacteriophage, the bacteriocins have proven useful for the typing/ identification of pathogenic bacterial strains [62, 63] .
The presence of prophages can be used to detect and type bacterial pathogens and define their roles in gene regulation and pathogenicity of their host bacteria [64, 65] . Newly emerging V. cholerae variants can be discriminated by PCR targeted to mobile genetic elements and phages [66] . Prophage polymorphism has been employed to detect and differentiate exfoliative toxin A-producing S. aureus strains [67] . Likewise, the chromosomal insertion sites of Shiga toxin-producing E. coli define the three major genotypes (clusters 1-3) among clinical isolates of E. coli O157:H7 [68] . In addition, it has been found that prophage regions are critical for competitiveness of P. aeruginosa strains [69] . Prophages also provide unique signatures for bacterial identification. For example, Bacillus anthracis genome encodes four prophages and the collective presence of all four is a unique feature of B. anthracis and can be exploited for developing a multiplex PCR assay for B. anthracis [70] . Similarly, the recent German outbreak strains can be distinguished from their near neighbor E. coli O104:H4 strains by prophage content [71] .
Experimental approaches to identify prophages in bacterial chromosomes rely on the induction of prophages by UV irradiation or chemical DNA damaging agents [72] . However, this approach is only applicable to intact prophages that can undergo excision from the chromosome and undergo the lytic life cycle to be detected as plaques on a bacterial lawn. In some pathogens, such as V. cholerae, only subpopulations of bacteria undergo lysis and produce toxin. Studies of these subpopulations require a method to isolate cells that are normally killed by the prophage after induction [73] . Methods such as recombination-based in vivo expression technology and selective in vivo expression technology have been developed for this purpose [73] [74] [75] .
Functional genomics of the phage infection process and the use of phage and phage proteins for pathogen control and detection Phages are found in nearly every environment where they have been searched for and they can transduce genetic markers between related host bacteria. As alluded to in an earlier section, phage-mediated horizontal gene transfer between intestinal bacteria and autochthonous bacteria is of interest with respect to bacterial pathogenicity [76] . For example, the presence of prophages enables Clostridium botulinum and C. difficile toxin production [77, 78] , increases Salmonella virulence [79] and influences gene expression within the Staphylococcus pathogenicity islands [80] . Phages with transduction or lysogenic potential are generally not desired in any biotechnological application and identification of such phages or of genes contributing to lysogeny in a phage is critical before embarking on any whole phage based therapeutic application. [81] . Also, temperate phages often possess a narrow host range which limits their utility as biocontrol agents but may be useful as diagnostic tools [82] .
Due to a general lack of functional annotation of many phage gene products and the enormous diversity seen in the strategies adopted by phages, our understanding of the mechanism of the phage infection process is rather sketchy at best. In general, functional data, which could bolster in silico prediction of protein function based on sequence homology, are lacking. Only a few model phages have been studied in detail with respect to their life cycle (mostly infecting Gram-negative organisms) and structure/ functions of only a few phage proteins have been determined. The infection of a bacterial cell by a bacteriophage is initiated by a highly specific and irreversible interaction of the phage particle associated protein to cell surface receptors, such as outer membrane proteins or LPS structures in Gram-negative bacteria or teichoic acids or the peptidoglycan backbone in Gram-positive bacteria. This binding is mediated by highly specific receptor binding protein (RBP) of the phage that is very difficult to predict simply based on sequence homology. Besides a trial-and-error cloning strategy of candidate receptor genes, genomics approaches such as structure prediction and identification of conserved domains play an important role in the discovery of RBP proteins. The three-dimensional (3D) atomic RBP structures of three Lactococcus siphoviruses (p2, bIL170 and TP901-1) have been solved by X-ray crystallography and Cryo-EM techniques [44] [45] [46] [47] . General saccharide and phosphoglycerol binding has been demonstrated for some RBPs [44, 83, 84] . The baseplate of Lactococcal phage Tuc2009 has been shown to possess a 6-fold symmetry with six RBP trimers attached around the baseplate and a tail-associated lysin located in the middle of the base plate [83] .
Bacteriophages of two other organisms have been subject to intensive research recently. Streptococcus thermophilus is an important organism in industrial fermentation. The RBP of the small Siphovirus DT1 of S. thermophilus is encoded by gp18 [85] . The receptors for S. thermophilus phages are most likely glucosamine, N-acetylglucosamine or rhamnose [86, 87] . Other phages of Streptococcus have been investigated for identifying the host receptor [87, 88] . Bacillus subtilis Siphovirus SPP1 has been the focus of intensive structural studies. Besides 3D structures of the virion and details of DNA packaging, the baseplate proteins (gp 22-24.1) have been investigated [89] [90] [91] . The baseplate proteins have been shown to be essential for binding of the host cell and hence may have utility in bacterial detection assays. Cell wall teichoic acids have been proposed as the major target of SPP1 reversible initial binding, followed by binding to the membrane receptor YueB. Adsorption to cell wall teichoic acids has been shown to accelerate irreversible binding to YueB [92] . Thus, these functional genomic approaches lay the foundation for modeling based structural prediction of phage encoded RBPs.
Following adsorption, the phage must penetrate the rigid cell wall and inject its DNA into the host cytosol. Specialized tail-located lytic proteins mediate localized cell wall degradation and allow DNA translocation. The potential application of lytic structural proteins (LSPs) in biocontrol is exemplified by the identification of improved adsorption of the SPO1-related phage EF34C infecting Enterococcus faecalis [93, 94] due to a spontaneous point mutation in a putative long tail fiber protein encoded by ORF31 [95] , using a functional genomics approach. With the exception of well-studied enteric phages such as bacteriophage P22 [96] , little is known about the molecular details of DNA transport across cell membranes, especially in phages infecting Gram-positive bacteria [97] . Localized cell wall hydrolysis is mediated by tail tip-associated lytic proteins (LPs) [98] [99] [100] . It is believed that LSPs are commonly found among all phages [101] [102] [103] . In Lactococcus phage Tuc2009, a tail-tip associated protein (Tal 2009 ) has been found to feature cell wall degrading activity [101, 104] . The presence of LSP proteins in phages infecting other Firmicutes has been demonstrated [103, 105, 106] . The LSP of Staphylococcus phage MR11 could be located at the tail tip [107] , whereas in mycobacteriophage TM4, the lytic activity lies in the tape measure protein [108] . Recently, a tail-associated muralytic enzyme was described for Staphylococcus phage K and its activity demonstrated [103] .
Infection of a bacterial host by a bacteriophage is usually accompanied by dramatic rearrangements in bacterial gene expression and changes in cell physiology and metabolism. Understanding these steps using functional genomics approaches may lead to development of rapid diagnostics and therapeutics against bacteria. After an initial takeover phase, the virus down-regulates cellular functions and reprograms the bacterial cell for virus progeny production. Later in the life cycle, virion proteins and progeny DNAs are produced, packaged and virions are assembled, finally resulting in cell lysis and release of progeny phage particles. In case of temperate bacteriophages, the infection process can be stalled at an early stage and the phage genome is integrated in the host chromosome, resulting in some cases, host gene disruption and possible effects on gene expression (e.g. as recently shown for comK disruption in Listeria by phage A118 [65] ). Once induced by stress signals, temperate phages enter into a lytic cycle and take over host cell functions. Many studies have focused on only certain stages of the infection process, although in some phages, the entire life cycle has been investigated. Escherichia coli phage T4 is one such example that has been extensively studied in using microarrays [109] and proteomics (described in [41, 98] and many more). Host modification and takeover functions have been described for some phages [110, 111] . Many studies have focused on the changes in gene expression and cell physiology during virus infection [112, 113] . Other authors have demonstrated the complete shutoff of macromolecular synthesis in the infected host [114, 115] . Such functional genomic approaches reveal specific phage-bacterial interactions in shutting down and take over of host machinery and also possibly provide new drug targets. The identification of DnaI (the helicase loader) as a target for ORF 104 of a S. aureus phage 77, led to the development of novel small molecule antimicrobial compounds that mimic the phage protein (ORF 104 product) activity (69) . More such studies are needed to unravel the various strategies that phages adopt to tame their host.
All stages in the bacteriophage life cycle can be harnessed for pathogen detection and for the development of novel antimicrobials. Bacterial detection can be achieved either by manipulation of the genomes of virulent phages to give a detectable signal during the infection process (reporter phages) or by the use of the highly specific phage binding proteins, either RBPs or the anchoring domain of endolysins [84, [116] [117] [118] for specific tagging and/or immobilization of bacteria. Phage tail lysins [102] and endolysins [119, 120] represent a novel class of lytic protein (enzybiotics) for pathogen control.
Another pathogen detection approach, which follows the genomics to protein function path, is the use or reporter bacteriophages. Reporter phages are usually virulent phages containing a genetically modified genome in which a reporter gene is expressed under the transcriptional control of phage promoters. Expression of the reporter gene upon infection of the susceptible host generates a detectable response. The advantage of such an approach is that only viable target cells are detected, as the expression of the reporter gene relies on successful infection and initiation of phage gene expression. Construction of such reporter phages requires functional genomic knowledge of the gene expression profiles and location of promoters and appropriate insertion sites for the reporter genes and the effect of reporter gene insertion on the overall phage gene expression and a productive life cycle. One of the early approaches involved cloning of the luxAB genes from Vibrio harveyi or Vibrio fischeri behind a strong late phase phage promoter of Listeria phage A511 [20] . This type of reporter assay has subsequently been developed for a number of other bacterium-phage pairs (i.e. Bacillus [23] , Salmonella [121] or Yersinia [22] ). In principle, nearly every available reporter gene can be used for diagnostic purposes (e.g. luc, ina, beta-galactosidase or fluorescent molecules [122] [123] [124] ). Recently, a hyperthermostable glycosidase reporter gene cloned into phage A511 was used for the detection of Listeria. The assay offers flexibility in the use of fluorescent, chemilumnescent or chromogenic substrates for pathogen detection [125] . The reporter-phage assay is highly specific, yields no false-positive results and is easy to conduct in a standard laboratory setting by lab personnel with little specialized experience or expertise. The assay detects only viable, phage-sensitive bacteria and is also somewhat dependent on correct folding of the reporter protein (which should be chosen accordingly) and incubation temperature [125] . Recently, phage genomes have been manipulated to express biotin-binding peptide on the capsid surface, which were subsequently captured upon adsorption to cognate bacteria using streptavidin coated quantum dots for high sensitive detection of bacteria [126, 127] .
Other approaches to pathogen detection harness the function of bacteriophage encoded enzymes. Phage genomes usually encode at least two types of highly specific cellular binding proteins. Tail proteins feature binding domains, which mediate the initial contact with the host cell surface (RBP proteins, see above). These are highly strain-or even serovarspecific and can be used for pathogen detection. They feature a single binding-site and are in this respect superior to antibodies, because no agglutination is triggered.
The final stage of a successful infection is marked by the release of the progeny virus particles. Phageencoded cell wall hydrolytic enzymes lyse the bacterial cell from within [119] . These enzymes are also very useful for pathogen detection and control. Large libraries of lytic enzyme-encoding genes identified by either genome sequencing, prophage identification or functional (meta-) genomics approaches [128] are available for different bacterial species, e.g. Streptococcus and Staphylococcus [120] . Phage lysins are composed of an enzymatic active domain(s) and a cell wall-binding domain(s) (CBDs), directing the enzyme to its target structure [119] . CBDs have efficiently been used to target and selectively decorate bacteria in several matrices and media [117, [129] [130] [131] . CBD domains can be fused to reporter molecules, such as Green Fluorescent Protein (GFP), for easy readout of the signal upon binding to the target bacteria. Different CBD molecules, tagged with different fluorophores can be used to simultaneously identify several different bacterial species or serovariants in a one-step multiplex assay [117] . CBDs feature equilibrium constants in the picomolar range and are highly species specific and more sensitive than conventional antibodies [117, 131] . Recently, CBD domains have been used in combination with gold screen-printed electrodes to develop a biosensor for Listeria [132] . Because of the usefulness of these small phage proteins in combination with powerful detection methods, we expect many more such biosensor platforms targeting many different bacteria to be developed in the near future.
In general, CBD proteins are not as effective for detection of Gram-negative cells, as the outer membrane precludes binding to the cell wall receptor structure. For Gram-negative bacteria, phage-tail based affinity molecules are much better suited for immobilization and detection. Moreover, these proteins exhibit similar desirable features as CBD molecules, such as high affinity, high specificity and a single binding site. Besides specific cell decoration, both CBDs and tail adhesins can also be used to immobilize bacterial cells, for example to paramagnetic beads. Enrichment of a specific pathogen from a complex matrix is possible with this technique in a matter of minutes, compared to hours or even days when using conventional enrichment methods [131] . Similar to methods employing whole phage particles, coupling of these phage proteins to specific surfaces for detection applications, paves the way for the development of a new class of biosensor based on phage proteins [133, 134] .
In conclusion, bacteriophage functional genomics offers exciting new possibilities for detection and control of bacterial pathogens. The high specificity of phages and some phage proteins to their bacterial hosts, combined with the absence of undesired side effects and the relatively straightforward discovery and large-scale production of phages make them ideal tools for food industry and medical applications. However, our knowledge of phage-encoded gene functions, and their influence on the bacterial host gene expression and our general understanding of the molecular diversity of phage life cycle are rather limited. Recent advances in genome sequencing, comparative genomics combined with functional genomic studies will undoubtedly play a major role in filling this knowledge gap and increase our understanding of phage biology for better utilization of these organisms for bacterial detection and therapeutics.
Key points
Bacteriophages offer exciting possibilities for the detection and biocontrol of bacterial pathogens. Next-generation sequencing technologies have boosted the number of complete phage genomic sequences available for functional genomic studies. Prophage identification by in silico or experimental methods is mandatory to understand pathogen biology and evolution and can be used for pathogen detection purposes.
Functional genomic studies addressing all stages of the bacteriophage infection cycle can be manipulated in developing methods for pathogen detection.
